CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0784

Clomiphene (Clomid) Raw

Filed under Raw Materials. The bureau holds 57 laboratory returns for this compound from 17 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

17 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760A710.09.910.023 May 202623 May 2026
Diju Peptides Wellness and CoCASE #VI-2026-0724X110.010.010.017 Dec 202417 Dec 2024
Tianjin Finder Chemical TFCCASE #VI-2026-0693A59.99.910.014 Nov 202516 Apr 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A59.58.910.021 May 202621 May 2026
Bfflist AMOCASE #VI-2026-0678X69.18.010.06 May 202524 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A88.97.99.724 May 202624 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A68.87.610.024 May 202624 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704A78.57.410.023 May 202623 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486A48.56.610.025 May 202625 May 2026
HealthTide BiotechCASE #VI-2026-0955X18.38.38.316 Mar 202516 Mar 2025
Bulk Peptide WholesaleCASE #VI-2026-0319A28.06.79.313 Feb 202524 May 2026
Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634X17.67.67.62 Apr 20252 Apr 2025
Kerisite Shenzhen InternationalCASE #VI-2026-0315X15.85.85.811 Jun 202511 Jun 2025
M-PeptidesCASE #VI-2026-0442X14.44.44.416 Mar 202516 Mar 2025
Lejian Biotech PeptideCASE #VI-2026-0746X10.30.30.317 Dec 202417 Dec 2024
Wuhan Newtop BiotechCASE #VI-2026-0676X10.00.00.024 Apr 202524 Apr 2025
Explicit SarmsCASE #VI-2026-0017X10.00.00.03 Jun 20253 Jun 2025

Open any subject to view the batch-level evidence for Clomiphene (Clomid) Raw alone.